Levocetirizin + Pharma

Levocetirizine, the active ingredient in Levocetirizin + Pharma, is a second‑generation antihistamine presented as an oral tablet for oral use. It selectively blocks peripheral H1 receptors, reducing the effects of histamine. It treats allergic rhinitis and chronic idiopathic urticaria in adults and adolescents, providing relief from nasal congestion, sneezing, itching and hives. GNH USA supplies Levocetirizin + Pharma as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide, ensuring consistent quality and regulatory compliance across global markets.

Levocetirizine is used to manage histamine‑mediated allergic conditions, primarily affecting the respiratory tract and skin. - Allergic rhinitis: reduces nasal congestion, sneezing, itching and runny nose. - Chronic idiopathic urticaria: alleviates hives and itching, improving quality of life. - Histamine‑mediated allergic symptoms: provides overall relief of itching, swelling and redness associated with allergic reactions.

Levocetirizine may cause adverse reactions, which are categorized by frequency and severity.

Common Side Effects: - Drowsiness: mild sedation or sleepiness, usually transient and not dose‑dependent. - Headache: transient cranial discomfort that often resolves without treatment. - Dry mouth: reduced salivary flow causing mild throat irritation.

Serious or Rare Side Effects: - Anaphylaxis: severe, potentially life‑threatening allergic reaction requiring immediate emergency care. - Stevens‑Johnson syndrome: rare, serious skin disorder with blistering and mucosal involvement. - Thrombocytopenia: significant reduction in platelet count that may increase bleeding risk.

When prescribing Levocetirine, clinicians should observe several precautionary measures to ensure safe use. - Assess patient history: evaluate for hypersensitivity to levocetirizine or other antihistamines. - Monitor renal function: dose adjustment may be required in severe renal impairment. - Caution in the elderly: increased susceptibility to sedation and anticholinergic effects. - Avoid driving if drowsiness occurs: advise patients to refrain from operating machinery until they know how the drug affects them. - Pregnancy and lactation: use only if clearly needed after risk‑benefit assessment. - Store at ambient temperature: keep below 25°C in the original packaging, protect from moisture.

Levocetirizine can interact with other medicines, altering its efficacy or safety profile.

Major Interactions (Avoid): - Ketoconazole or erythromycin: may increase levocetirizine plasma levels, raising risk of side effects. - CNS depressants (e.g., benzodiazepines, alcohol): additive sedation, should be avoided.

Moderate Interactions (Monitor Closely): - Theophylline: may reduce antihistamine effect, monitor symptom control. - Rifampicin: may lower levocetirine concentrations, consider dose adjustment. - Other antihistamines: combined use can increase anticholinergic burden, monitor for excessive sedation.